keyword
https://read.qxmd.com/read/38379641/case-report-thrombotic-thrombocytopenic-purpura-in-a-pregnant-woman-with-lupus-membranous-nephropathy-a-diagnostic-challenge
#21
Marina Leiva, Gustavo Navarro, J Daniel Carpio, Leopoldo Ardiles
A 27-year-old female at 20th week of pregnancy was admitted with edema, foamy urine, but normal blood pressure. Her blood count was normal, she had proteinuria of 3 g/day, creatinine 0.4 mg/dl, albumin 2.4 g/dl, and cholesterol 355 mg/dl. Antinuclear antibodies 1/160, but Anti-DNA, anticardiolipin antibodies and lupus anticoagulant were negative, with normal serum C3 and C4. A renal biopsy showed secondary membranous glomerulopathy, most likely lupus class V pure. Steroids, azathioprine, and aspirin were initiated, up to 28 weeks of pregnancy, when she developed severe hypertension, photopsia, headache, anasarca, extensive bruising of the extremities, severe anemia, thrombocytopenia, and creatinine rose to 2...
2024: Front Nephrol
https://read.qxmd.com/read/38378970/treatment-of-pulmonary-arterial-hypertension-in-patients-with-connective-tissue-diseases-a-systematic-review-and-meta-analysis
#22
JOURNAL ARTICLE
Mustafa Erdogan, Sinem Nihal Esatoglu, Burcak Kilickiran Avci, Gulen Hatemi
The evidence for the treatment of connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) mostly depends on subgroup or post hoc analysis of randomized controlled trials (RCTs). Thus, we performed a meta-analysis of RCTs that reported outcomes for CTD-PAH. PubMed and EMBASE were searched for CTD-PAH treatment. The selected outcomes were functional class (FC) change, survival rates, 6-min walk distance (6-MWD), clinical worsening (CW), N-terminal prohormone BNP (NT-proBNP), pulmonary vascular resistance (PVR), mean pulmonary arterial pressure (mPAP), right atrial pressure (RAP), and cardiac index (CI)...
February 20, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38378664/longitudinal-patterns-and-predictors-of-response-to-standard-of-care-therapy-in-lupus-nephritis-data-from-the-accelerating-medicines-partnership-lupus-network
#23
JOURNAL ARTICLE
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, Katherine Preisinger, Brooke Z Cohen, Kristina Deonaraine, Devyn Zaminski, Maria Dall'Era, Kenneth Kalunian, Andrea Fava, H Michael Belmont, Ming Wu, Chaim Putterman, Jennifer Anolik, Jennifer L Barnas, Betty Diamond, Anne Davidson, David Wofsy, Diane Kamen, Judith A James, Joel M Guthridge, William Apruzzese, Deepak A Rao, Michael H Weisman, Michelle Petri, Jill Buyon, Richard Furie
BACKGROUND: Leveraging the Accelerating Medicines Partnership (AMP) Lupus Nephritis (LN) dataset, we evaluated longitudinal patterns, rates, and predictors of response to standard-of-care therapy in patients with lupus nephritis. METHODS: Patients from US academic medical centers with class III, IV, and/or V LN and a baseline urine protein/creatinine (UPCR) ratio ≥ 1.0 (n = 180) were eligible for this analysis. Complete response (CR) required the following: (1) UPCR < 0...
February 20, 2024: Arthritis Research & Therapy
https://read.qxmd.com/read/38343803/factors-associated-with-worsening-interstitial-fibrosis-tubular-atrophy-in-lupus-nephritis-patients-undergoing-repeat-kidney-biopsy
#24
Daming Shao, Alejandra Londoño Jimenez, Maria Salgado Guerrero, Shudan Wang, Anna Broder
Background Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE). Interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies strongly predicts progression to end-stage renal disease. However, factors associated with progression of IFTA are not known. The objective of this study was to evaluate the demographic, clinical, and histopathological factors at the time of index kidney biopsies that are associated with worsening IFTA on repeat biopsies. Methods Patients with LN Class I to V or mixed LN on index biopsies who underwent a clinically indicated repeat biopsy between 2004 and 2020 were identified...
January 23, 2024: Research Square
https://read.qxmd.com/read/38331818/macrophage-subpopulations-in-pediatric-patients-with-lupus-nephritis-and-other-inflammatory-diseases-affecting-the-kidney
#25
JOURNAL ARTICLE
Mira Sandersfeld, Maike Büttner-Herold, Fulvia Ferrazzi, Kerstin Amann, Kerstin Benz, Christoph Daniel
BACKGROUND: Macrophages play an important role in the pathogenesis of lupus nephritis (LN), but less is known about macrophage subtypes in pediatric LN. Here we compared renal inflammation in LN with other inflammatory pediatric kidney diseases and assessed whether inflammation correlates with clinical parameters. METHODS: Using immunofluorescence microscopy, we analyzed renal biopsies from 20 pediatric patients with lupus nephritis (ISN/RPS classes II-V) and pediatric controls with other inflammatory kidney diseases for infiltration with M1-like (CD68 + /CD206 - , CD68 + /CD163 -), M2a-like (CD206 + /CD68 +), and M2c-like macrophages (CD163 + /CD68 +) as well as CD3 + T-cells, CD20 + B-cells, and MPO + neutrophilic granulocytes...
February 8, 2024: Arthritis Research & Therapy
https://read.qxmd.com/read/38322624/trna-derived-small-rnas-a-novel-regulatory-small-noncoding-rna-in-renal-diseases
#26
JOURNAL ARTICLE
Dan Li, Xian Xie, Ni Yin, Xueqin Wu, Bin Yi, Hao Zhang, Wei Zhang
BACKGROUND: tRNA-derived small RNAs (tsRNAs) are an emerging class of small noncoding RNAs derived from tRNA cleavage. SUMMARY: With the development of high-throughput sequencing, various biological roles of tsRNAs have been gradually revealed, including regulation of mRNA stability, transcription, translation, direct interaction with proteins and as epigenetic factors, etc. Recent studies have shown that tsRNAs are also closely related to renal disease. In clinical acute kidney injury (AKI) patients and preclinical AKI models, the production and differential expression of tsRNAs in renal tissue and plasma were observed...
February 2024: Kidney Diseases
https://read.qxmd.com/read/38319120/male-dingo-urinary-scents-code-for-age-class-and-wild-dingoes-respond-to-this-information
#27
JOURNAL ARTICLE
Benjamin J J Walker, Mike Letnic, Martin P Bucknall, Lyn Watson, Neil R Jordan
Chemical information in canid urine has been implicated in territoriality and influences the spacing of individuals. We identified the key volatile organic compound (VOC) components in dingo (Canis lupus dingo) urine and investigated the potential role of scents in territorial spacing. VOC analysis, using headspace gas chromatography-mass spectrometry (GC-MS), demonstrated that the information in fresh urine from adult male dingoes was sufficient to allow statistical classification into age categories. Discriminant function analyses demonstrated that the relative amounts or combinations of key VOCs from pre-prime (3-4 years), prime (5-9 years), and post-prime (≥10 years) males varied between these age categories, and that scents exposed to the environment for 4 (but not 33) days could still be classified to age categories...
February 6, 2024: Chemical Senses
https://read.qxmd.com/read/38294724/clinico-serological-associations-of-urinary-activated-leukocyte-cell-adhesion-molecule-in-systemic-lupus-erythematosus-and-lupus-nephritis
#28
JOURNAL ARTICLE
Arwa S Amer, Samia M Abdel Moneam, Nashwa I Hashaad, Eman M Yousef, Dalia M Abd El-Hassib
BACKGROUND: Lupus nephritis (LN) is one of the major complications associated with Systemic Lupus Erythematosus (SLE). Activated leukocyte cell adhesion molecule (ALCAM or CD166) is a promising urine biomarker that binds to CD6, a receptor found on lymphocytes. This binding results in T-cell activation, proliferation, and recruitment, which causes tissue inflammation and may explain the pathophysiology of LN. AIM OF WORK: Investigate the urinary ALCAM level in SLE, study its relationship to disease activity, and clarify the association with LN activity and histopathology...
January 31, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38293588/evaluating-sex-differences-in-the-characteristics-and-outcomes-of-lupus-nephritis-a-systematic-review-and-meta-analysis
#29
REVIEW
Salman B Mahmood, Muhammad Aziz, Deepthi Malepati, Wade Lee-Smith, Justin Clark, Ann Brearley, Patrick H Nachman
INTRODUCTION: More frequent and severe lupus nephritis (LN) has been reported in men compared to women, but data are limited and inconsistent. We conducted a meta-analysis of the literature to compare the histopathologic findings and outcomes between men and women with biopsy-proven LN. METHODS: A systematic search of MEDLINE, Embase, Cochrane, and Web of Science databases was conducted through February 2021. Clinical information was extracted and synthesized from 25 studies that met inclusion criteria (1,210 men and 6,635 women)...
2024: Glomerular diseases
https://read.qxmd.com/read/38270788/patients-preferences-for-systemic-lupus-erythematosus-treatments-a-discrete-choice-experiment
#30
JOURNAL ARTICLE
Hannah Collacott, Andrea Phillips-Beyer, Nicolas Krucien, Bruno Flamion, Kevin Marsh
BACKGROUND: Symptoms of systemic lupus erythematosus (SLE) vary between patients, but those of increased disease activity typically include musculoskeletal and mucocutaneous manifestations such as joint pain, swelling, and rashes. Several treatment options are available to patients with SLE with variable efficacy. Many treatments, especially corticosteroids, cause unwanted side effects, although little is currently known about patients' preferences for treatments of SLE. OBJECTIVE: We aimed to identify which attributes of SLE treatment are valued by patients and to quantify their relative importance...
January 25, 2024: Patient
https://read.qxmd.com/read/38264625/association-of-mitochondrial-pyruvate-carrier-with-the-clinical-and-histological-features-in-lupus-nephritis
#31
JOURNAL ARTICLE
Huanhuan Zhu, Chen Chen, Luhan Geng, Qing Li, Chengning Zhang, Lin Wu, Bo Zhang, Suyan Duan, Changying Xing, Yanggang Yuan
BACKGROUND: Mounting evidence suggests that mitochondrial dysfunction contributes to lupus nephritis (LN) pathogenesis. Mitochondrial pyruvate carrier 1 (MPC1) and mitochondrial pyruvate carrier 2 (MPC2) mediating pyruvate transport from the cytoplasm to the mitochondrial matrix, determines the cell survival and cellular energy supply. Here, we aimed to investigate the association of mitochondrial pyruvate carrier expression with the clinical and histological features in LN. METHODS: Patients with biopsy-proven proliferative LN (class III and class IV, n=18) and membranous LN (class V, n=18) were included...
2024: International Journal of Nephrology and Renovascular Disease
https://read.qxmd.com/read/38259384/rehabilitation-in-systemic-lupus-erythematosus-with-class-4-lupus-nephritis-secondary-to-pneumonia-a-case-report
#32
Trupti P Loya, H V Sharath, Neha Arya, Reva D Rajurkar, Nandini C Baheti
We herein report an undisclosed case of systemic lupus erythematosus (SLE) with class 4 lupus nephritis (LN). It is an autoimmune disease that occurs when the body's immune system attacks its tissues. It results in significant tissue damage and inflammation in the afflicted organs. It may affect the kidneys, brain, lungs, skin, joints, and blood vessels. A 30-year-old female presented to Acharya Vinoba Bhave Rural Hospital (AVBRH) with the complaint of breathlessness, cough with expectoration, and fever for two months...
December 2023: Curēus
https://read.qxmd.com/read/38258904/urine-proteomic-signatures-of-histological-class-activity-chronicity-and-treatment-response-in-lupus-nephritis
#33
JOURNAL ARTICLE
Andrea Fava, Jill Buyon, Laurence Magder, Jeff Hodgin, Avi Rosenberg, Dawit S Demeke, Deepak A Rao, Arnon Arazi, Alessandra Ida Celia, Chaim Putterman, Jennifer H Anolik, Jennifer Barnas, Maria Dall'Era, David Wofsy, Richard Furie, Diane Kamen, Kenneth Kalunian, Judith A James, Joel Guthridge, Mohamed G Atta, Jose Monroy Trujillo, Derek Fine, Robert Clancy, H Michael Belmont, Peter Izmirly, William Apruzzese, Daniel Goldman, Celine C Berthier, Paul Hoover, Nir Hacohen, Soumya Raychaudhuri, Anne Davidson, Betty Diamond, Michelle Petri
Lupus nephritis (LN) is a pathologically heterogenous autoimmune disease linked to end-stage kidney disease and mortality. Better therapeutic strategies are needed as only 30%-40% of patients completely respond to treatment. Noninvasive biomarkers of intrarenal inflammation may guide more precise approaches. Because urine collects the byproducts of kidney inflammation, we studied the urine proteomic profiles of 225 patients with LN (573 samples) in the longitudinal Accelerating Medicines Partnership in RA/SLE cohort...
January 23, 2024: JCI Insight
https://read.qxmd.com/read/38258530/analysis-of-clinical-immunological-characteristics-damage-and-survival-in-300-turkish-systemic-lupus-erythematosus-patients
#34
JOURNAL ARTICLE
Senem Tekeoglu, Duygu Temiz Karadag, Ozlem Ozdemir Isik, Ayten Yazici, Ayse Cefle
OBJECTIVE: This retrospective study aimed to conduct a comprehensive analysis of Turkish Systemic Lupus Erythematosus (SLE) patients of Caucasian ethnicity, focusing on their clinical, immunological, and therapeutic characteristics, damage accural and mortality. PATIENTS AND METHODS: We carried out a retrospective assessment of 300 SLE patients diagnosed between 2001 and 2017 at Kocaeli University Rheumatology Clinic. Demographic data, clinical manifestations, immunological profiles, treatment approaches, disease-related damage, and survival information were collected...
March 2024: Lupus
https://read.qxmd.com/read/38257325/portable-mid-infrared-spectroscopy-combined-with-chemometrics-to-diagnose-fibromyalgia-and-other-rheumatologic-syndromes-using-rapid-volumetric-absorptive-microsampling
#35
JOURNAL ARTICLE
Shreya Madhav Nuguri, Kevin V Hackshaw, Silvia de Lamo Castellvi, Haona Bao, Siyu Yao, Rija Aziz, Scott Selinger, Zhanna Mikulik, Lianbo Yu, Michelle M Osuna-Diaz, Katherine R Sebastian, M Monica Giusti, Luis Rodriguez-Saona
The diagnostic criteria for fibromyalgia (FM) have relied heavily on subjective reports of experienced symptoms coupled with examination-based evidence of diffuse tenderness due to the lack of reliable biomarkers. Rheumatic disorders that are common causes of chronic pain such as rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and chronic low back pain are frequently found to be comorbid with FM. As a result, this can make the diagnosis of FM more challenging. We aim to develop a reliable classification algorithm using unique spectral profiles of portable FT-MIR that can be used as a real-time point-of-care device for the screening of FM...
January 15, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38255243/targeting-tlr-signaling-cascades-in-systemic-lupus-erythematosus-and-rheumatoid-arthritis-an-update
#36
JOURNAL ARTICLE
George D Kalliolias, Efthimia K Basdra, Athanasios G Papavassiliou
Evidence from animal models and human genetics implicates Toll-like Receptors (TLRs) in the pathogenesis of Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). Endosomal TLRs sensing nucleic acids were proposed to induce lupus-promoting signaling in dendritic cells, B cells, monocytes, and macrophages. Ligation of TLR4 in synovial macrophages and fibroblast-like synoviocytes (FLSs) by endogenous ligands was suggested to induce local production of mediators that amplify RA synovitis. Inhibition of TLRs using antagonists or monoclonal antibodies (mAbs) that selectively prevent extracellular or endosomal TLR ligation has emerged as an attractive treatment strategy for SLE and RA...
January 9, 2024: Biomedicines
https://read.qxmd.com/read/38255238/early-diagnosis-of-fibromyalgia-using-surface-enhanced-raman-spectroscopy-combined-with-chemometrics
#37
JOURNAL ARTICLE
Haona Bao, Kevin V Hackshaw, Silvia de Lamo Castellvi, Yalan Wu, Celeste Matos Gonzalez, Shreya Madhav Nuguri, Siyu Yao, Chelsea M Goetzman, Zachary D Schultz, Lianbo Yu, Rija Aziz, Michelle M Osuna-Diaz, Katherine R Sebastian, Monica M Giusti, Luis Rodriguez-Saona
Fibromyalgia (FM) is a chronic muscle pain disorder that shares several clinical features with other related rheumatologic disorders. This study investigates the feasibility of using surface-enhanced Raman spectroscopy (SERS) with gold nanoparticles (AuNPs) as a fingerprinting approach to diagnose FM and other rheumatic diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), osteoarthritis (OA), and chronic low back pain (CLBP). Blood samples were obtained on protein saver cards from FM ( n = 83), non-FM ( n = 54), and healthy (NC, n = 9) subjects...
January 9, 2024: Biomedicines
https://read.qxmd.com/read/38250842/latent-class-analysis-identifies-distinct-phenotypes-of-systemic-lupus-erythematosus-predictive-of-flares-after-mrna-covid-19-vaccination-results-from-the-coronavirus-national-vaccine-registry-for-immune-diseases-singapore-convin-sing
#38
JOURNAL ARTICLE
Tao Ming Sim, Manjari Lahiri, Margaret Ma, Peter Pak-Moon Cheung, Anselm Mak, Warren Fong, Stanley Angkodjojo, Chuanhui Xu, Kok Ooi Kong, Thaschawee Arkachaisri, Kee Fong Phang, Teck Choon Tan, Qai Ven Yap, Yiong Huak Chan, Melonie Sriranganathan, Tyng Yu Chuah, Nur Emillia Roslan, Yih Jia Poh, Annie Law, Amelia Santosa, Sen Hee Tay
UNLABELLED: We recently reported that messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccination was associated with flares in 9% of patients with systemic lupus erythematosus (SLE). Herein, we focused our analysis on patients from a multi-ethnic Southeast Asian lupus cohort with the intention of identifying distinct phenotypes associated with increased flares after mRNA COVID-19 vaccination. METHODS: Six hundred and thirty-three SLE patients from eight public healthcare institutions were divided into test and validation cohorts based on healthcare clusters...
December 27, 2023: Vaccines
https://read.qxmd.com/read/38238724/monogenic-systemic-lupus-erythematosus-onset-in-a-13-year-old-boy-with-noonan-like-syndrome-a-case-report-and-literature-review
#39
JOURNAL ARTICLE
Patricia Morán-Álvarez, Alessandra Gianviti, Francesca Diomedi-Camassei, Monia Ginevrino, Fabrizio de Benedetti, Claudia Bracaglia
BACKGROUND: Childhood systemic lupus erythematosus (cSLE) has been considered as a polygenic autoimmune disease; however, a monogenic lupus-like phenotype is emerging with the recent recognition of several related novel high-penetrance genetic variants. RASopathies, a group of disorders caused by mutations in the RAS/MAPK pathway, have been recently described as a cause of monogenic lupus. CASE PRESENTATION: We present a 13-year-old boy with Noonan-like syndrome with loose anagen hair who developed a monogenic lupus...
January 18, 2024: Pediatric Rheumatology Online Journal
https://read.qxmd.com/read/38229315/the-role-of-igg4-in-systemic-lupus-erythematosus-implications-for-pathogenesis-and-therapy
#40
REVIEW
Yanyan Liu, Yingjian Wang, Mengsi Hu, Shoufang Xu, Feiyu Jiang, Yetao Han, Zhiwei Liu
Immunoglobulin (Ig) G4 has a distinctive nature, and its involvement in autoimmune disorders is a subject of ongoing debate and uncertainty. A growing body of evidence indicates that IgG4 may play a pathogenic role in the development of systemic lupus erythematosus (SLE). The IgG4 autoantibodies have the capability to bind autoantigens in a competitive manner with other Ig classes, thereby forming immune complexes (ICs) that are noninflammatory in nature. This is due to the low affinity of IgG4 for both the Fc receptors and the C1 complement molecule, which results in a diminished inflammatory response in individuals with SLE...
January 2024: Journal of Biochemical and Molecular Toxicology
keyword
keyword
116543
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.